Skip to content

Bruker BRKR Restructuring Reserve

Restructuring Reserve at other companies

Revvity logo
RevvityRVTY
IDEX logo
IDEXIEX
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserve.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's restructuring reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's restructuring reserve?
Bruker (BRKR) reported restructuring reserve of $29.8M in Q1 2026.
How has Bruker's restructuring reserve changed year-over-year?
Bruker's restructuring reserve increased by 220.4% year-over-year, from $9.3M to $29.8M.
What is the long-term trend for Bruker's restructuring reserve?
Over 5 years (2020 to 2025), Bruker's restructuring reserve has grown at a 26.9% compound annual growth rate (CAGR), from $9.8M to $32.2M.